Energy Production and Metabolism — MCQs

Energy Production and Metabolism Indian Medical PG Practice Questions and MCQs

Question 181: Which of the following is an effect of dinitrophenol on oxidative phosphorylation?

A. Inhibition of cytochrome b
B. Blockade of both electron transport and ATP synthesis
C. Inhibition of ATP synthesis with normal electron transport (Correct Answer)
D. Inhibition of electron transport but not ATP synthesis

Explanation: **Explanation:** **Mechanism of Action (The Correct Answer):** 2,4-Dinitrophenol (DNP) is a classic **uncoupler** of oxidative phosphorylation. It is a lipophilic weak acid that can easily cross the inner mitochondrial membrane. It carries protons ($H^+$) from the intermembrane space directly into the mitochondrial matrix, bypassing the $F_0F_1$ ATP synthase complex. This **dissipates the proton gradient**. Consequently, the Electron Transport Chain (ETC) continues to function (often at an accelerated rate to compensate), but the energy is released as **heat** instead of being captured as ATP. Thus, ATP synthesis is inhibited while electron transport remains normal or increased. **Analysis of Incorrect Options:** * **Option A:** Cytochrome b is a component of Complex III. Its inhibition would stop the flow of electrons, which is not the mechanism of uncouplers. * **Option B:** This describes the effect of **Respiratory Chain Inhibitors** (like Cyanide or Carbon Monoxide). These stop the ETC, which secondarily stops ATP synthesis. Uncouplers specifically "uncouple" these two processes. * **Option D:** This is physiologically impossible. ATP synthesis (via the chemiosmotic theory) requires the proton gradient generated by electron transport. You cannot have ATP synthesis if the ETC is inhibited. **High-Yield Clinical Pearls for NEET-PG:** * **Physiological Uncoupler:** **Thermogenin** (UCP1) found in brown adipose tissue of newborns; it generates heat to maintain body temperature. * **Other Uncouplers:** Aspirin (in high doses), Dicumarol, and CCCP. * **Clinical Presentation of DNP Toxicity:** Hyperthermia (due to heat release), tachycardia, and metabolic acidosis. It was historically used as a weight-loss drug but banned due to fatal toxicity. * **Key Distinction:** Inhibitors (e.g., Oligomycin) stop both ETC and ATP synthesis, whereas Uncouplers stop ATP synthesis but **increase** oxygen consumption and ETC activity.

Question 182: Which complex is NADH-Coenzyme Q reductase in the electron transport chain?

A. Complex I (Correct Answer)
B. Complex II
C. Complex III
D. Complex IV

Explanation: **Explanation:** The Electron Transport Chain (ETC) consists of a series of protein complexes located in the inner mitochondrial membrane that facilitate oxidative phosphorylation. **Why Complex I is correct:** **Complex I** is formally known as **NADH-Coenzyme Q reductase** (or NADH dehydrogenase). Its primary function is to accept two electrons from NADH (produced in the TCA cycle) and transfer them to **Coenzyme Q (Ubiquinone)**. During this process, it pumps four protons ($H^+$) from the mitochondrial matrix into the intermembrane space, contributing to the proton gradient. **Why other options are incorrect:** * **Complex II (Succinate-Q reductase):** This complex accepts electrons from **FADH₂** (derived from the conversion of succinate to fumarate). It does not pump protons and is not the entry point for NADH. * **Complex III (Q-cytochrome c oxidoreductase):** This complex transfers electrons from reduced Coenzyme Q (ubiquinol) to **Cytochrome c**. * **Complex IV (Cytochrome c oxidase):** This is the terminal complex that transfers electrons from Cytochrome c to **molecular oxygen**, reducing it to water ($H_2O$). **High-Yield Clinical Pearls for NEET-PG:** * **Inhibitors of Complex I:** Rotenone, Amobarbital (Amytal), and Piericidin A. * **Leber’s Hereditary Optic Neuropathy (LHON):** A mitochondrial disorder often caused by mutations in genes encoding subunits of Complex I, leading to bilateral central vision loss. * **Proton Pumping:** Complexes I, III, and IV act as proton pumps; Complex II does **not**. * **Mobile Carriers:** Coenzyme Q (lipid-soluble) and Cytochrome c (water-soluble) are the two mobile electron carriers in the ETC.

Question 183: In starvation, which substance does the brain primarily utilize for energy?

A. Amino acids
B. Cellulose
C. Ketone bodies (Correct Answer)
D. Glycerol

Explanation: **Explanation:** In the early stages of starvation, the brain relies on glucose derived from glycogenolysis and gluconeogenesis. However, as starvation progresses (typically beyond 3–4 days), glucose levels fall, and the body shifts to mobilizing fatty acids from adipose tissue. Since long-chain fatty acids cannot cross the blood-brain barrier, the liver converts them into **Ketone Bodies** (Acetoacetate and β-hydroxybutyrate). These water-soluble molecules cross the blood-brain barrier and serve as the primary fuel source for the brain during prolonged fasting, sparing muscle protein from excessive breakdown. **Analysis of Incorrect Options:** * **A. Amino Acids:** While the liver uses glucogenic amino acids (like alanine) for gluconeogenesis, the brain does not directly oxidize amino acids as a primary energy source. * **B. Cellulose:** This is a structural polysaccharide in plants. Humans lack the enzyme cellulase; therefore, it cannot be digested or utilized for energy. * **D. Glycerol:** Released during lipolysis, glycerol is used by the liver for gluconeogenesis. The brain itself does not utilize glycerol directly for its energy requirements. **NEET-PG High-Yield Pearls:** * **The "Glucose Sparing Effect":** Ketone body utilization by the brain reduces the requirement for gluconeogenesis, thereby slowing down muscle wasting (proteolysis). * **Key Enzyme:** The brain can use ketones because it possesses the enzyme **thiophorase** (succinyl-CoA:3-ketoacid CoA-transferase), which the liver lacks (preventing the liver from consuming the ketones it produces). * **Energy Shift:** In prolonged starvation, up to 75% of the brain's energy requirements are met by ketone bodies.

Question 184: The phenomenon by which cancer cells are able to sustain and proliferate under adverse conditions of hypoxia is?

A. Warburg effect (Correct Answer)
B. Wanton effect
C. Wormian bone
D. Wolf's law

Explanation: ### Explanation **Correct Answer: A. Warburg Effect** The **Warburg effect** refers to the unique metabolic shift in cancer cells where they prefer **aerobic glycolysis** over oxidative phosphorylation. Even in the presence of oxygen (and especially under hypoxia), cancer cells convert the majority of glucose into **lactate** rather than sending it to the mitochondria. * **Mechanism:** This rapid glucose uptake and fermentation provide the cell with carbon skeletons (intermediates) necessary for the biosynthesis of nucleic acids, proteins, and lipids required for rapid proliferation. * **Survival:** By relying on glycolysis, cancer cells can survive in the poorly vascularized, hypoxic core of a solid tumor where oxygen levels are insufficient for normal mitochondrial function. **Analysis of Incorrect Options:** * **B. Wanton effect:** This is a distractor term with no relevance to biochemistry or medical physiology. * **C. Wormian bone:** These are small, irregular accessory bones found within the sutures of the skull (e.g., seen in Osteogenesis Imperfecta or Cleidocranial Dysplasia). * **D. Wolff’s law:** A principle in orthopedics stating that bone grows or remodels in response to the physical loads/stress placed upon it. **High-Yield Clinical Pearls for NEET-PG:** 1. **PET Scan Basis:** The Warburg effect is the clinical basis for **18F-FDG PET scans**. Since cancer cells have a high rate of glycolysis, they take up the radiolabeled glucose analog (FDG) much faster than normal tissues. 2. **Key Enzyme:** Cancer cells often overexpress **Hexokinase II** and **GLUT1/3** transporters to facilitate this high glucose flux. 3. **HIF-1α:** Under hypoxia, **Hypoxia-Inducible Factor 1-alpha** is stabilized, which upregulates glycolytic enzymes and VEGF, further driving the Warburg phenotype.

Question 185: Which complex of the electron transport chain is not associated with the liberation of energy?

A. Complex I
B. Complex II (Correct Answer)
C. Complex III
D. Complex IV

Explanation: **Explanation:** The Electron Transport Chain (ETC) consists of five complexes located in the inner mitochondrial membrane. The liberation of energy in the ETC is directly coupled to the **pumping of protons ($H^+$)** from the mitochondrial matrix into the intermembrane space, creating an electrochemical gradient used for ATP synthesis. **Why Complex II is the correct answer:** Complex II (**Succinate Dehydrogenase**) is the only complex in the ETC that **does not pump protons**. It transfers electrons from Succinate to FAD, and then to Coenzyme Q. Because the redox potential change across Complex II is relatively small, it does not release enough free energy to transport protons across the membrane. Consequently, it does not contribute directly to the proton motive force required for ATP production. **Why the other options are incorrect:** * **Complex I (NADH Dehydrogenase):** Pumps **4 protons** per NADH molecule. It is the largest complex and a major site of energy liberation. * **Complex III (Cytochrome bc1 complex):** Pumps **4 protons** via the Q-cycle. * **Complex IV (Cytochrome c Oxidase):** Pumps **2 protons** into the intermembrane space while reducing oxygen to water. **High-Yield Clinical Pearls for NEET-PG:** * **Dual Role:** Complex II is the only enzyme that participates in both the **TCA Cycle** and the **ETC**. * **Location:** Unlike other TCA enzymes which are soluble in the matrix, Complex II is **membrane-bound**. * **Inhibitors:** Complex II is inhibited by **Malonate** (competitive inhibitor) and **Carboxin**. * **P:O Ratio:** Because Complex II bypasses the proton-pumping Complex I, FADH2 oxidation yields only **1.5 ATP**, whereas NADH oxidation (starting at Complex I) yields **2.5 ATP**.

Question 186: An obese young woman ingested a banned drug which was once used for weight reduction and she developed high fever. The drug is known to affect the ATP formation in the electron transport chain. What could that drug be?

A. Barbiturate
B. Malonate
C. 2,4-dinitrophenol (Correct Answer)
D. Rotenone

Explanation: ### Explanation **Correct Option: C. 2,4-dinitrophenol (DNP)** The clinical presentation of weight loss followed by high fever (hyperpyrexia) after drug ingestion is a classic description of **Uncoupler** toxicity. * **Mechanism:** 2,4-DNP is a lipophilic protonophore. It picks up protons ($H^+$) from the intermembrane space and carries them across the inner mitochondrial membrane into the matrix, bypassing the $F_0F_1$ ATP synthase complex. * **Result:** This dissipates the proton gradient. While the Electron Transport Chain (ETC) continues to operate at a rapid rate (consuming oxygen), the energy is not captured as ATP. Instead, the energy is released as **heat**, leading to fatal hyperthermia. * **Historical Context:** DNP was used in the 1930s for weight loss because it "wastes" metabolic fuel, but it was banned due to its narrow therapeutic index and severe side effects. **Incorrect Options:** * **A. Barbiturates:** These are inhibitors of **Complex I** (NADH Dehydrogenase). They block the flow of electrons, thereby stopping both the ETC and ATP production, rather than uncoupling them. * **B. Malonate:** This is a classic **competitive inhibitor of Succinate Dehydrogenase** (Complex II). It competes with succinate for the active site. * **D. Rotenone:** A common insecticide that acts as an inhibitor of **Complex I**. Like barbiturates, it prevents the establishment of a proton gradient. **NEET-PG High-Yield Pearls:** * **Physiological Uncoupler:** **Thermogenin** (UCP1) found in brown adipose tissue; essential for non-shivering thermogenesis in neonates. * **Other Uncouplers:** High doses of **Aspirin (Salicylates)**, Dicumarol, and Bilirubin. * **Key Distinction:** *Inhibitors* (e.g., Cyanide, CO) stop oxygen consumption; *Uncouplers* (e.g., DNP) **increase** oxygen consumption while decreasing ATP synthesis.

Question 187: Which of the following is a high-energy compound?

A. ADP
B. ATP (Correct Answer)
C. Glucose-6-phosphate
D. AMP

Explanation: **Explanation:** In biochemistry, **high-energy compounds** are defined as those having a standard free energy of hydrolysis ($\Delta G'^\circ$) more negative than **-30.5 kJ/mol** (the energy released by ATP). **Correct Answer: B. ATP (Adenosine Triphosphate)** ATP is the "universal energy currency" of the cell. It contains two high-energy **phosphoanhydride bonds**. When the terminal phosphate bond is hydrolyzed to form ADP and Pi, it releases approximately **-30.5 kJ/mol (-7.3 kcal/mol)** of energy. This energy is used to drive endergonic (energy-requiring) reactions in the body, such as muscle contraction and active transport. **Analysis of Incorrect Options:** * **A. ADP (Adenosine Diphosphate):** While ADP does contain one high-energy phosphoanhydride bond, it is the product of ATP hydrolysis. In the context of this standard question, ATP is the primary high-energy donor. * **C. Glucose-6-phosphate:** This is a **low-energy phosphate**. Its hydrolysis releases only about -13.8 kJ/mol. It lacks the unstable anhydride bonds found in ATP. * **D. AMP (Adenosine Monophosphate):** AMP contains a **phosphoester bond**, which is a low-energy bond. It cannot be hydrolyzed further to release significant energy for cellular work. **High-Yield NEET-PG Pearls:** 1. **Highest Energy Compound:** **Phosphoenolpyruvate (PEP)** is the highest energy compound in the body ($\Delta G'^\circ = -61.9$ kJ/mol), followed by 1,3-bisphosphoglycerate and Creatine Phosphate. 2. **Classification:** Compounds with $\Delta G'^\circ$ more negative than -30.5 kJ/mol are "High Energy," while those less negative (like G6P or AMP) are "Low Energy." 3. **Creatine Phosphate:** Acts as a rapid energy reservoir in muscles to regenerate ATP during the first few seconds of exercise.

Question 188: The malate shuttle plays a crucial role in which metabolic pathway?

A. Glycogenolysis
B. Glycolysis
C. Gluconeogenesis (Correct Answer)
D. HMP shunt

Explanation: ### Explanation The **Malate-Aspartate Shuttle** is essential for **Gluconeogenesis** because it facilitates the transport of carbon skeletons and reducing equivalents across the impermeable inner mitochondrial membrane. **Why Gluconeogenesis is correct:** In the first step of gluconeogenesis, Pyruvate is converted to **Oxaloacetate (OAA)** by *Pyruvate Carboxylase* inside the mitochondria. However, the subsequent enzyme, *PEP Carboxykinase (PEPCK)*, is primarily located in the cytosol. Since OAA cannot directly cross the mitochondrial membrane, it is reduced to **Malate**. Malate exits to the cytosol, where it is re-oxidized back to OAA, providing both the substrate for glucose synthesis and the NADH required for the glyceraldehyde-3-phosphate dehydrogenase reaction. **Why other options are incorrect:** * **Glycolysis:** This pathway occurs entirely in the cytosol. While the malate shuttle helps transport NADH produced during glycolysis into the mitochondria for ATP production, the shuttle itself is not a "step" of the pathway. * **Glycogenolysis:** This involves the breakdown of glycogen into Glucose-1-Phosphate in the cytosol; it does not require mitochondrial transport mechanisms. * **HMP Shunt:** This pathway occurs exclusively in the cytosol to produce NADPH and ribose-5-phosphate; it has no direct involvement with mitochondrial shuttles. ### High-Yield Clinical Pearls for NEET-PG: * **Location:** The Malate Shuttle is most active in the **Liver, Kidney, and Heart**. * **Alternative:** In skeletal muscle and brain, the **Glycerol 3-Phosphate Shuttle** is used instead, which is less energy-efficient (yields 1.5 ATP vs. 2.5 ATP per NADH). * **Key Enzyme:** The conversion of OAA to Malate is catalyzed by **Malate Dehydrogenase**. * **Diagnostic Link:** Defects in gluconeogenic enzymes or shuttles often present with fasting hypoglycemia and lactic acidosis.

Question 189: What is the energy currency of the cell?

A. Nucleotide diphosphate
B. Nucleotide triphosphate (Correct Answer)
C. Deoxynucleotide diphosphate
D. Nucleotide monophosphate

Explanation: **Explanation:** The primary energy currency of the cell is **Adenosine Triphosphate (ATP)**, which belongs to the chemical class of **Nucleotide Triphosphates (NTPs)**. **Why Nucleotide Triphosphate is correct:** Energy in the cell is stored within high-energy phosphate bonds (specifically phosphoanhydride bonds). When the terminal phosphate bond of an NTP (like ATP or GTP) is hydrolyzed, it releases a significant amount of Gibbs free energy (approximately -30.5 kJ/mol or -7.3 kcal/mol). This energy is used to drive endergonic reactions, muscle contraction, and active transport. While ATP is the most common, other NTPs like GTP (used in protein synthesis and gluconeogenesis), UTP (glycogen synthesis), and CTP (lipid synthesis) also serve as energy carriers. **Why the other options are incorrect:** * **Nucleotide diphosphate (ADP/GDP):** These are the "discharged" forms of the energy currency. While they contain one high-energy bond, they typically act as precursors that must be re-phosphorylated to triphosphates to drive cellular work. * **Nucleotide monophosphate (AMP):** These contain only an ester bond, which is low-energy. High levels of AMP in a cell signal a "low energy status," activating pathways like AMPK to stimulate catabolism. * **Deoxynucleotide diphosphate (dNDP):** These are intermediates in DNA synthesis and do not function as general energy carriers for metabolic reactions. **High-Yield Clinical Pearls for NEET-PG:** * **Universal Currency:** ATP is the link between catabolism (energy-releasing) and anabolism (energy-consuming). * **Total Body Content:** The human body maintains only about 250g of ATP at any given time but turns over its own body weight in ATP daily. * **Mitochondria:** Known as the "powerhouse," it generates the bulk of ATP via **Oxidative Phosphorylation**. * **Substrate-Level Phosphorylation:** A minor way to generate ATP/GTP independent of the electron transport chain (e.g., in Glycolysis and the TCA cycle).

Question 190: Cyanide inhibits which of the following?

A. Pyruvate kinase
B. Cytochrome C oxidase (Correct Answer)
C. Enolase
D. None of the above

Explanation: **Explanation:** **Correct Answer: B. Cytochrome C oxidase** The Electron Transport Chain (ETC) is the final stage of aerobic respiration, occurring in the inner mitochondrial membrane. **Cytochrome C oxidase (Complex IV)** is the terminal enzyme of the ETC, responsible for transferring electrons to oxygen to form water. **Cyanide (CN⁻)** acts as a potent metabolic poison by binding to the **ferric (Fe³⁺) iron** in the heme group of Cytochrome C oxidase. This binding inhibits the enzyme, halting the flow of electrons. Consequently, the proton gradient collapses, ATP synthesis stops, and cells shift to anaerobic metabolism, leading to rapid cellular hypoxia and death despite adequate oxygen supply (histotoxic hypoxia). **Why other options are incorrect:** * **A. Pyruvate kinase:** This is a key regulatory enzyme in **Glycolysis** that converts phosphoenolpyruvate to pyruvate. It is inhibited by ATP and Alanine, not cyanide. * **C. Enolase:** This is another glycolytic enzyme. It is classically inhibited by **Fluoride** (used in blood collection tubes to prevent glycolysis). **High-Yield Clinical Pearls for NEET-PG:** * **Antidote for Cyanide:** Amyl nitrite/Sodium nitrite (induces methemoglobinemia to sequester cyanide) and **Hydroxocobalamin** (binds cyanide to form cyanocobalamin). * **Other Complex IV Inhibitors:** Carbon Monoxide (CO), Azide (N₃⁻), and Hydrogen Sulfide (H₂S). * **Classic Presentation:** Bitter almond odor on the breath and cherry-red skin discoloration. * **Complex III Inhibitor:** Antimycin A. * **Complex I Inhibitor:** Rotenone, Amobarbital.

Practice by Chapter

Bioenergetics and Thermodynamics

Practice Questions

ATP as Energy Currency

Practice Questions

Tricarboxylic Acid Cycle

Practice Questions

Electron Transport Chain

Practice Questions

Oxidative Phosphorylation

Practice Questions

Mitochondrial Diseases

Practice Questions

Uncouplers and Inhibitors of Oxidative Phosphorylation

Practice Questions

Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate

Practice Questions

Energy Yield from Nutrients

Practice Questions

Metabolic Rate and Basal Metabolism

Practice Questions

Brown Adipose Tissue and Thermogenesis

Practice Questions

Oxygen Toxicity and Free Radicals

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free